Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Several other large investors also recently […]
Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Other institutional investors and hedge funds […]
Joseph Klein III Sells 6,000 Shares of Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Stock wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Sees Large Increase in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price target boosted by Oppenheimer from $65.00 to $72.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other research firms also recently weighed in on IONS. Royal Bank of Canada lifted their price target […]